Brosch, S; Haak, S; Lorenz, B et al.
Role of interleukin-22 (IL-22) in murine cutaneous leishmaniasisEXPERIMENTAL DERMATOLOGY. Bd. 19. H. 2. 2010 S. 200-200
Zimmermann, T; Hoppe-Lotichius, M; Korner, A et al.
ROLE OF THE CYP2D6 POOR METABOLIZER STATUS ON THE FIBROSIS PROGRESSION AFTER LIVER TRANSPLANTATIONTRANSPLANT INTERNATIONAL. Bd. 23. 2010 S. 3-3
Kasaj, A; Klein, M; Dupont, J et al.
Root Surface Colonization by Fibroblasts Following Different Regenerative Treatment Modalities -AADR vom 3.-6. März 2010 in Washington, DC2010
Hermann, A; Suess, C; Fauser, M et al.
Rostro-Caudal Gradual Loss of Cellular Diversity Within the Periventricular Regions of the Ventricular System (vol 27, pg 928, 2009)STEM CELLS. Bd. 28. H. 4. 2010 S. 843-843
Liuni, A; Luca, MC; Gori, T et al.
Rosuvastatin Prevents Conduit Artery Endothelial Dysfunction Induced by Ischemia and Reperfusion by a Cyclooxygenase-2-Dependent MechanismJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. Bd. 55. H. 10. 2010 S. 1002-1006
Lehmann, ML; Selinski, S; Blaszkewicz, M et al.
Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer riskARCHIVES OF TOXICOLOGY. Bd. 84. H. 12. 2010 S. 967-978
Balci, S; Ergun, MA; Lechno, S et al.
Rubinstein-Taybi Syndrome in First Cousins With Different De Novo MutationsAMERICAN JOURNAL OF MEDICAL GENETICS PART A. Bd. 152A. H. 4. 2010 S. 1036-1038
Pfeiffer, N; Scherzer, ML; Maier, H et al.
Safety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapyClinical Ophthalmology. Bd. 1. H. 4. 2010 S. 459-466
Ramaswami, U; Parini, R; Beck, M
Safety of agalsidase alfa in Fabry disease patients under 7 years oldMOLECULAR GENETICS AND METABOLISM. Bd. 99. H. 2. 2010 S. S32-S32
Kamin, W; Kopp, MV; Erdnuess, F et al.
Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneouslyPEDIATRIC ALLERGY AND IMMUNOLOGY. Bd. 21. H. 1. 2010 S. E160-E165